ALBHF (Alibaba Health Information Technology) EBITDA per Share: $0.02 (TTM As of Mar. 2026)


ALBHF Alibaba Health Information Technology Ltd ALBHF
55 GF Score
Price $0.42
GF Value $0.68
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology EBITDA per Share?

Alibaba Health Information Technology ALBHF +2.44% 55 EBITDA per Share is $0.02 as of Mar. 2026. GuruFocus rates ALBHF with a GF Score™ of 55/100 and a GF Value™ of $0.68 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 528 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 88.45% on this metric.

Alibaba Health Information Technology's EBITDA per Share for the six months ended in Mar. 2026 was $0.01. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.02.

During the past 12 months, the average EBITDA per Share Growth Rate of Alibaba Health Information Technology was 48.10% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 45.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Alibaba Health Information Technology's EBITDA per Share or its related term are showing as below:

ALBHF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -78.3   Med: -8.4   Max: 95.1
Current: 45.4

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Alibaba Health Information Technology was 95.10% per year. The lowest was -78.30% per year. And the median was -8.40% per year.

ALBHF's 3-Year EBITDA Growth Rate is ranked better than
88.45% of 528 companies
in the Healthcare Providers & Services industry
Industry Median: 10.05 vs ALBHF: 45.40

Alibaba Health Information Technology's EBITDA for the six months ended in Mar. 2026 was $127 Mil.

During the past 12 months, the average EBITDA Growth Rate of Alibaba Health Information Technology was 48.80% per year. During the past 3 years, the average EBITDA Growth Rate was 54.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Alibaba Health Information Technology was 106.30% per year. The lowest was -109.60% per year. And the median was -24.70% per year.


Alibaba Health Information Technology  (OTCPK:ALBHF) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Alibaba Health Information Technology EBITDA per Share Related Terms


Alibaba Health Information Technology EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology EBITDA per Share Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.01 0.01 0.01 0.02

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01
ALBHF
55GF Score
Alibaba Health Information Technology Ltd ALBHF
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Alibaba Health Information Technology's EBITDA per Share for the fiscal year that ended in Mar. 2026 is calculated as

EBITDA per Share(A: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=337.903/16198.925
=0.02

Alibaba Health Information Technology's EBITDA per Share for the quarter that ended in Mar. 2026 is calculated as

EBITDA per Share(Q: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=127.008/16195.905
=0.01

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $0.02 mean?
Alibaba Health Information Technology (ALBHF) has a EBITDA per Share of $0.02 as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Alibaba Health Information Technology and its competitors. According to the industry distribution chart, Alibaba Health Information Technology ranks #61 out of 528 companies in the Healthcare Providers & Services industry, placing it in the top 11.6%.
Is Alibaba Health Information Technology's EBITDA per Share too high?
Alibaba Health Information Technology's current EBITDA per Share is $0.02. The Healthcare Providers & Services industry median EBITDA per Share is 10.05. Alibaba Health Information Technology's value of $0.02 is 99.8% below this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #61 out of 528 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's EBITDA per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #61 out of 528 companies for EBITDA per Share. This places Alibaba Health Information Technology in the top 12% of its industry — outperforming the majority of peers. The industry median EBITDA per Share is 10.05. Alibaba Health Information Technology's value of $0.02 is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Healthcare Providers & Services company?
The median EBITDA per Share among Healthcare Providers & Services companies is 10.05, based on 528 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current EBITDA per Share of $0.02 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median EBITDA per Share is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current EBITDA per Share is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.68, compared to a current price of $0.42 — trading 38.2% below its estimated fair value. The current EBITDA per Share is $0.02 and 99.8% below the Healthcare Providers & Services industry median of 10.05. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current EBITDA per Share is $0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $0.42 is trading 38.2% below its estimated GF Value™ of $0.68. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBHF:

  • EBITDA per Share: $0.02
  • GF Value™: $0.68 vs. price of $0.42 (38.2% below fair value)
  • GF Score™: 55/100 with 2 warning signs
  • Industry Position: 99.8% below the Healthcare Providers & Services median (#61 of 528)

No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score

Get the complete analysis for ALBHF

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.68
GF Value